Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse

D J Scott1, M A Hull, E J Cartwright

  • 1Molecular Medicine Unit, University of Leeds, St James's University Hospital, Leeds, England, UK.

Gastroenterology
|October 19, 2001
PubMed
Abstract

Insights

The inducible nitric oxide synthase (Nos2) gene acts to prevent intestinal tumors in a mouse model. Nos2 deficiency increased adenoma formation and did not affect cyclooxygenase 2 (Cox-2) levels.

Area of Science:

  • Gastroenterology
  • Oncology
  • Molecular Biology

Background:

  • The role of inducible nitric oxide synthase (Nos2) in intestinal cancer is not well understood.
  • Conflicting data exist regarding Nos2's influence on cyclooxygenase 2 (Cox-2), a known tumor promoter.

Purpose of the Study:

  • To investigate the effect of a null Nos2 genotype on intestinal tumorigenesis.
  • To determine if Nos2 influences Cox-2 expression and activity in the Apc(Min/+) mouse model.

Main Methods:

  • Generated Apc(Min/+)Nos2(-/-) mice.
  • Compared adenoma characteristics between Apc(Min/+)Nos2(+/+) and Apc(Min/+)Nos2(-/-) mice.
  • Assessed Nos2 mRNA, Cox-2 expression, and Cox-2 activity in intestinal tissue and macrophages.

Main Results:

  • Apc(Min/+)Nos2(-/-) mice exhibited significantly more intestinal adenomas than controls.
  • Nos2 mRNA expression was lower in adenomas compared to normal tissue.
  • No significant differences in Cox-2 expression or activity were observed between genotypes.

Conclusions:

  • Nos2 plays an anti-neoplastic role in this mouse model of intestinal polyposis.
  • Nos2 does not modulate Cox-2 expression or activity in the Apc(Min/+) mouse model.